Radiology
ImpriMed Personalized Prediction Profile
ImpriMed
AI cancer analysis platform using machine learning to process live cancer cells and predict optimal treatment paths for canine lymphoma and leukemia. Combines drug response testing with artificial intelligence for personalized medicine, delivering results within 3-7 days.
Visit Website →This tool was discovered via automated search. Information may be incomplete. Verify details before evaluation.